Validates the use of the RAPID score for predicting mortality in pleural infections, directly informing the management of patients undergoing pleural interventions like chest tubes and medical thoracoscopy.
Clinical context
Undiagnosed pleural effusions remain a diagnostic challenge in interventional pulmonology. While image-guided pleural biopsy is standard, diagnostic yield for malignant pleural disease can be limited by sampling error. Needle-based Confocal Laser Endomicroscopy (nCLE) offers real-time, in vivo microscopic imaging of the pleura, potentially increasing diagnostic accuracy by guiding biopsies toward high-yield areas, thereby reducing the need for repeat procedures or more invasive surgical interventions.
Strengths and weaknesses
Strengths:
- Multicenter, randomized controlled trial (RCT) design provides high-level evidence compared to existing observational data.
- Standardized protocol for nCLE application and biopsy technique minimizes operator variability.
- Clear definition of primary and secondary endpoints, including diagnostic yield and safety profiles (e.g., pneumothorax, bleeding).
Weaknesses:
- The study is a protocol paper; actual clinical outcomes are pending.
- Potential for selection bias in patient enrollment, as patients with highly suspicious imaging may be prioritized.
- The learning curve associated with nCLE interpretation may impact the generalizability of the results to centers with less experience.
- The study design may not fully account for the heterogeneity of pleural pathologies (e.g., benign vs. malignant, inflammatory vs. neoplastic).
Takeaway
Keep a close eye on the final results of COLLABORATION-II. If nCLE proves to significantly increase diagnostic yield, it could become a standard adjunct in the diagnostic workup of undiagnosed exudative effusions. For now, continue to rely on established ultrasound-guided biopsy techniques, but be aware that real-time microscopic guidance may soon shift the paradigm in how we approach pleural sampling.
Abstract
Keep reading
N opens the next oneUltrasound estimation of pleural fluid volume is a core procedural skill for thoracentesis and chest tube placement, making this directly relevant to IP practice.
Directly impacts pleural management and staging by maximizing the diagnostic yield of routine thoracentesis for molecular testing in malignancy.
Pleural fluid obtained during thoracentesis or medical thoracoscopy should be preserved for cfDNA molecular testing when tissue is limited.
Relevant to pleural disease management and post-procedural care of trapped or non-expandable lungs.
Provides useful risk stratification tools for managing secondary spontaneous pneumothorax patients who often require IP intervention.